Influence of Alcohol Marketing Stimuli in Adults With Regular Alcohol Consumption
NCT ID: NCT05125783
Last Updated: 2025-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
287 participants
OBSERVATIONAL
2022-02-07
2023-12-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Studies on the impact of alcohol marketing focus for the most part on young adolescents and the links between marketing exposure and alcohol initiation. But beyond these links, little work has been done on the impact of alcohol marketing on vulnerable subjects with regular alcohol consumption. Alcohol consumption is one of the very first causes of hospitalization in France. The damage is often limited to the notion of risks of dependence, but it can appear as soon as consumption of 1 standard unit/day and mainly concerns the 45-64 year olds. To investigator knowledge, there are no studies on the impact of alcohol marketing carried out among regular alcohol users with moderate or severe alcohol use disorders.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perception of the Risks of Alcohol and Individual Vulnerabilities in Young Adults
NCT03876132
Impact of a Brief Motivational Intervention Including Counter-marketing Arguments With a Population of Patients With Moderate to Severe Alcohol Use Disorders Who Are Followed up on an Outpatient Basis (Primary Care or Addictology) (DEPREV_Phase 3)
NCT04881500
Impact of Marketing of Alcohol Products on Young People
NCT03818750
Campus Health Intervention Projects UBC Site
NCT00278733
Impact of Alcohol Labels in a Real-World Setting
NCT06915298
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire
Completion of the questionnaire by the patient after consultation with the practitioner.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with moderate to severe alcohol use disorders (beyond 3 out of 11 criteria on the DSM-5 scale)
* Non-opposition of the patient
Exclusion Criteria
* Patient who has already participated in phase 1 of the project
* Non-comprehension of the written French language
* Refusal to participate in the study
* Patient of legal age, deprived of liberty by a judicial or administrative decision or unable to express their consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ecole des Hautes Etudes en Santé Publique
OTHER
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Les Apsyades
Bouguenais, , France
François-Néri VANDERMERSCH
Bouguenais, , France
Morgane GUILLOU-LANDREAT
Brest, , France
Jean-Pierre SIMSON
Brest, , France
Pascale ROZEC
Landerneau, , France
Benoit SCHRECK
Nantes, , France
Hôpital Paul Brousse
Villejuif, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
29BRC21.0178
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.